scPharmaceuticals Inc. (SCPH)
5.67
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025

scPharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-91.72-85.15-54.81-36.84-28.03-32.21
Depreciation & Amortization
0.170.150.630.470.440.4
Other Amortization
4.494.49----
Loss (Gain) From Sale of Assets
000.01---
Loss (Gain) From Sale of Investments
--0.12-2.11-0.240.12-
Stock-Based Compensation
5.335.444.862.842.372
Provision & Write-off of Bad Debts
0.060.06----
Other Operating Activities
22.6817.68-1.49-0.450.550.67
Change in Accounts Receivable
-13.35-7.29-4.49---
Change in Inventory
0.55-5.16-7.61-1.23--
Change in Accounts Payable
60.595.561.77-2.371.21
Change in Other Net Operating Assets
-0.07-1.230.22-0.89-0.230.24
Operating Cash Flow
-65.86-70.54-59.24-34.58-27.15-27.69
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
-0.02-0.02-0.04-0.02-0.01-
Investment in Securities
-29.3220.01-45.8432.14-33.46
Investing Cash Flow
-0.0229.319.97-45.8632.13-33.46

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Issued
-46.77-47.3--
Long-Term Debt Repaid
--50--17.5-2.5-
Net Debt Issued (Repaid)
-3.23-3.23-29.8-2.5-
Issuance of Common Stock
54.0854.2314.8547.980.0561.31
Repurchase of Common Stock
--0.17--0.05-0.08-0.16
Other Financing Activities
17.3319.25--0.5--0.8
Financing Cash Flow
68.1970.0814.8577.23-2.5360.35

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
2.3128.84-24.43-3.212.45-0.81

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
-65.88-70.56-59.28-34.6-27.16-27.69
Free Cash Flow Growth
------
Free Cash Flow Margin
-131.84%-194.21%-436.14%---
Free Cash Flow Per Share
-1.27-1.58-1.54-1.22-0.99-1.13
Levered Free Cash Flow
-41.91-46.89-40.22-19.81-17.08-16.01
Unlevered Free Cash Flow
-42.57-46.65-35.14-17.75-15.47-14.39

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash Interest Paid
5.866.045.942.562.041.99
Cash Income Tax Paid
0.210.210.250.190.210.23
Change in Working Capital
-6.87-13.09-6.32-0.35-2.61.45
SEC Filings: 10-K · 10-Q